| Exposure to attention deficit hyperactivity disorder medications during pregnancy. | |
| | |
MedLine Citation:
|
PMID: 17872810 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
QUESTION: An 18-year-old patient of mine, currently under treatment for attention deficit hyperactivity disorder (ADHD) with methylphenidate, just found out that she is pregnant. What are the risks for the baby when the mother uses ADHD medications during pregnancy? ANSWER: Available evidence for amphetamines suggests no increased risk of malformations with use of therapeutic doses, and inadvertent exposure during pregnancy is unlikely to be harmful. Human data for methylphenidate and atomoxetine treatment in pregnancy are very limited. Documented cases do not suggest teratogenicity, but we cannot rule out this risk with the information available. |
| | |
Authors:
|
Caitlin Humphreys; Facundo Garcia-Bournissen; Shinya Ito; Gideon Koren |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Canadian family physician Médecin de famille canadien Volume: 53 ISSN: 1715-5258 ISO Abbreviation: Can Fam Physician Publication Date: 2007 Jul |
Date Detail:
|
Created Date: 2007-09-17 Completed Date: 2007-10-18 Revised Date: 2009-11-18 |
Medline Journal Info:
|
Nlm Unique ID: 0120300 Medline TA: Can Fam Physician Country: Canada |
Other Details:
|
Languages: eng Pagination: 1153-5 Citation Subset: IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Abnormalities, Drug-Induced
/
prevention & control* Attention Deficit Disorder with Hyperactivity / diagnosis, drug therapy* Central Nervous System Stimulants / adverse effects*, therapeutic use Congenital Abnormalities Decision Making Drug Toxicity Female Humans Infant, Newborn Methylphenidate / adverse effects, therapeutic use Pregnancy Pregnancy Complications / drug therapy* Propylamines / adverse effects, therapeutic use Risk Assessment |
| Chemical | |
Reg. No./Substance:
|
0/Central Nervous System Stimulants; 0/Propylamines; 113-45-1/Methylphenidate; 83015-26-3/atomoxetine |
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Room for improvement: patients' experiences of primary care in Quebec before major reforms.
Next Document: Carpal tunnel syndrome and vitamin B6.